
Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 732.45
2026-05-21 13:40:14With a decisive surge to Rs 732.45 on 21 May 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a 66.4% rally from its low of Rs 439.95 over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader market shows signs of volatility.
Read MoreBoard Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026.
06-Aug-2026 | Source : BSELincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Lincoln Pharmaceuticals Ltd has Informed BSE that the meeting of the Board of Directors of the Company is Scheduled on 13/08/2026 Inter alia to consider and approve Unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jul-2026 | Source : BSEPursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended June 30 2026.
Closure of Trading Window
24-Jun-2026 | Source : BSEIntimation of Trading Window Closure for the Quarter ended June 30 2026.
Corporate Actions
13 Aug 2026
Lincoln Pharmaceuticals Ltd has declared 18% dividend, ex-date: 12 Sep 25
Lincoln Pharmaceuticals Ltd has announced 10:2 stock split, ex-date: 19 Mar 09
No Bonus history available
No Rights history available